skip to Main Content

Cancer Services

Skin Cancer

Please see below all current skin cancer clinical trials of the Central Coast Cancer Centre.

Name: SGNLV-005

Open-Label Phase 2 Study of Ladiratuzumab Vedotin (LV) for unresectable locally advanced metastatic
solid tumours.

Principal Investigator: Dr Matthew Wong
Study Coordinator: Bronwyn Raymond
Status: Recruiting
Condition: Melanoma
External page link More information about SGNLV-005

Name: c-POST

A randomized, placebo-controlled, double-blind study of adjuvant Cemiplimab versus placebo after surgery and radiation therapy in patients with high risk cutaneous squamous cell carcinoma.

Principal Investigator: Dr Craig Kukard
Study Coordinator: Cassandra Rubio
Status: Recruiting
Condition: Skin Cancer
External page link More information about c-POST

Name: ACSCC REGENERON 2810

A phase 2 study of REGN2810, a fully human monoclonal antibody to programmed death-1 (PD-1), in patients with advanced cutaneous squamous cell carcinoma.

Principal Investigator: Dr Craig Kukard
Study Coordinator: Cassandra Rubio
Status: Closed
Condition: Skin Cancer
External page link More information about ACSCC REGENERON 2810

More information

For more information about medical oncology clinical trials, please contact the Nurse Unit Manager on 02 4320 9890 or see:

Internal page Research and Clinical Trials

Back To Top